Login to Your Account

Appeals court: FDA research questions don’t equal invention

By Mari Serebrov
Regulatory Editor

Thursday, January 26, 2017

An FDA request for more data doesn’t disqualify patent claims stemming from the research, the U.S. Court of Appeals for the Federal Circuit ruled Thursday in Cumberland Pharmaceuticals Inc. v. Mylan Inc.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription